GE HealthCare Technologies Inc. $GEHC Holdings Raised by Cerity Partners LLC

Cerity Partners LLC increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 20.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 373,570 shares of the company’s stock after purchasing an additional 64,017 shares during the quarter. Cerity Partners LLC’s holdings in GE HealthCare Technologies were worth $28,055,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Meiji Yasuda Asset Management Co Ltd. lifted its position in shares of GE HealthCare Technologies by 6.7% in the 1st quarter. Meiji Yasuda Asset Management Co Ltd. now owns 6,862 shares of the company’s stock worth $554,000 after buying an additional 429 shares during the last quarter. Empowered Funds LLC grew its position in shares of GE HealthCare Technologies by 6.1% during the 1st quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock valued at $2,328,000 after buying an additional 1,665 shares during the last quarter. Glenview Trust co raised its stake in GE HealthCare Technologies by 4.4% during the first quarter. Glenview Trust co now owns 3,294 shares of the company’s stock worth $266,000 after acquiring an additional 139 shares during the period. Focus Partners Wealth lifted its holdings in GE HealthCare Technologies by 7.2% in the first quarter. Focus Partners Wealth now owns 749,768 shares of the company’s stock worth $60,514,000 after acquiring an additional 50,272 shares during the last quarter. Finally, IFM Investors Pty Ltd boosted its stake in GE HealthCare Technologies by 0.8% in the first quarter. IFM Investors Pty Ltd now owns 86,698 shares of the company’s stock valued at $6,997,000 after acquiring an additional 727 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 2.8%

Shares of NASDAQ:GEHC opened at $88.16 on Friday. The company has a 50 day moving average of $80.05 and a 200-day moving average of $76.55. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. The firm has a market cap of $40.16 billion, a P/E ratio of 18.21, a P/E/G ratio of 3.34 and a beta of 1.08. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, topping the consensus estimate of $1.05 by $0.02. The firm had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be issued a $0.035 dividend. The ex-dividend date is Friday, January 9th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 2.89%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on GEHC shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Citigroup increased their target price on GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Stifel Nicolaus upped their price target on shares of GE HealthCare Technologies from $90.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday. Barclays initiated coverage on shares of GE HealthCare Technologies in a report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price objective on the stock. Finally, Evercore ISI restated an “outperform” rating and issued a $95.00 target price on shares of GE HealthCare Technologies in a research report on Monday. Seven equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average price target of $88.17.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.